Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference27 articles.
1. Kurmi M, Golla VM, Kumar S, Sahu A, Singh S. Stability behaviour of antiretroviral drugs and their combinations. 1: characterization of tenofovir disoproxil fumarate degradation products by mass spectrometry. RSC Adv. 2015;5:96117–29.
2. Dore GJ, Cooper DA, Pozniak AL, Dejesus E, Zhong L, Miller MD, et al. for the 903 and 907 study teams, efficacy of TDF in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus. J Infect Dis. 2004;189:1185–92.
3. Duarte-Rojo A, Heathcote EJ. Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B. Therap Adv Gastroenterol. 2010;3:107–19.
4. Chen J-Z, Liao Z-W, Huang F-L, Su R-K, Wang W-B, Cheng X-Y, et al. Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load. Sci Rep. 2017;7:4132.
5. Parienti J-J, Prazuck T, Peyro-Saint-Paul L, Fournier A, Valentin C, Brucato S, et al. Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: a pilot, randomized, open-label phase 2 trial. E Clinical Medicine. 2021;38:100993.